Timothy Ullmann

Assistant Professor

Albany Medical College

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Timothy Ullmann is an Assistant Professor at Albany Medical College, specializing in the field of endocrine surgery and thyroid cancer research. His recent articles address significant topics including the management of low-risk differentiated thyroid cancer, gender inequities in academic promotions, and the implications of holistic application scoring on interview offers. Dr. Ullmann's work also investigates the molecular mechanisms of thyroid carcinoma and treatment disparities, contributing to advancements in surgical practices and patient care quality.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Julie Ann Sosa

Leon Goldman, MD Distinguished Professor of Surgery and Chair, Dept of Surgery

University of California, San Francisco

UNITED STATES

View details

David Kim

UNITED STATES

View details

Chantal Pauli

Universität Zurich Medizinische Fakultät

SWITZERLAND

View details

Sanziana Roman

University of California, San Francisco

UNITED STATES

View details

Irene Min

Research scientist/ Associate Professor

Houston Methodist Research Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Timothy Ullmann

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

The Landmark Series: Extent of Surgery for Low-Risk Differentiated Thyroid Cancer

Bias Perpetuates Bias: ChatGPT Learns Gender Inequities in Academic Surgery Promotions

Impact of Holistic Application Scoring on Interview Offers

Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma

Delay in Surgery for Papillary Thyroid Cancer: A Proxy for Lower-Quality Care?

Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis

Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.

Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration.

Exposure to Polybrominated Diphenyl Ether Flame Retardants Causes Deoxyribonucleic Acid Damage in Human Thyroid Cells In Vitro

Disparities in Treatment for Differentiated Thyroid Cancer.

Endocrine surgeons are performing more thyroid lobectomies for low-risk differentiated thyroid cancer since the 2015 ATA guidelines

ASO Visual Abstract: RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype

RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype

Association of the Affordable Care Act with access to highest-volume centers for patients with thyroid cancer

Collaborators (5)

Julie Ann Sosa

David Kim

Chantal Pauli

Sanziana Roman

Irene Min

Make your next move.